Joydeep Goswami B Tech, PhD, MS, MBA

Joydeep Goswami has been President, Clinical Next Generation Sequencing and Oncology Division (CSD) since July 2016. CSD is focused on serving the targeted sequencing needs of customers in research and clinical applications, with an emphasis on oncology. Prior to his current role, Joydeep held various executive positions leading global businesses including Protein & Cell Analysis, Stem Cells and Regenerative Medicine and leading Life Technologies’ businesses in Japan and Asia. Before joining Thermo Fisher through the acquisition of Life Technologies, Joydeep worked at McKinsey & Company.